Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Income from Continuing Operations (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Income from Continuing Operations for 5 consecutive years, with 14363000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 28.96% to 14363000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 55312000.0 through Dec 2025, up 33.94% year-over-year, with the annual reading at 54663000.0 for FY2025, 34.72% up from the prior year.
  • Income from Continuing Operations hit 14363000.0 in Q4 2025 for Kezar Life Sciences, down from 10689000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10689000.0 in Q3 2025 to a low of 32260000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 18189350.0 across 5 years, with a median of 17201500.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 77.44% in 2023 and later skyrocketed 47.38% in 2025.
  • Year by year, Income from Continuing Operations stood at 14212000.0 in 2021, then decreased by 27.93% to 18181000.0 in 2022, then tumbled by 77.44% to 32260000.0 in 2023, then skyrocketed by 37.33% to 20218000.0 in 2024, then grew by 28.96% to 14363000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for KZR at 14363000.0 in Q4 2025, 10689000.0 in Q3 2025, and 13704000.0 in Q2 2025.